| |
| |
|
| Insider
Information: |
Rosenwald Lindsay A Md |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
37,549,400 |
|
|
Indirect Shares
|
13,489,834 |
|
|
| Direct
Value |
$70,800,206 |
|
|
|
Indirect Value
|
$51,326,555 |
|
|
| Total
Shares |
51,039,234 |
|
|
| Total
Value |
$122,126,762 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
8
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genta Inc De |
GNTAQ |
10% Owner |
2003-07-14 |
21,531,885 |
2004-02-13 |
656,191 |
Premium* |
|
|
Soligenix Inc Common |
SNGX |
10% Owner |
2004-02-12 |
0 |
2004-02-12 |
3,230,922 |
Premium* |
|
|
TG Therapeutics Inc |
TGTX |
10% Owner |
2005-05-11 |
2,649,321 |
2005-05-11 |
2,682,507 |
Premium* |
|
|
Cypress Bioscience Inc |
CYPB |
10% Owner |
2004-01-09 |
0 |
2004-01-13 |
2,210,848 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2006-05-22 |
1,735,863 |
2006-05-22 |
320,786 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
10% Owner |
2005-09-13 |
476,678 |
2005-09-13 |
737,777 |
Premium* |
|
|
Chem Rx Corporation |
CHRXU |
Officer, Director, 10%... |
2005-10-21 |
584,375 |
2005-10-21 |
584,375 |
Premium* |
|
|
Velcera Inc |
VLCR |
10% Owner |
2006-01-17 |
121,205 |
|
0 |
Premium* |
|
|
Fortress Biotech, Inc. |
FBIO |
President, CEO & Chair... |
2024-01-05 |
2,863,905 |
2017-01-01 |
2,367,666 |
Premium* |
|
|
National Holdings Corp |
NHLD |
10% Owner |
2016-09-12 |
7,037,482 |
2016-09-12 |
522,292 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
Director |
2023-06-13 |
50,123 |
2017-07-10 |
0 |
Premium* |
|
|
Avenue Therapeutics, Inc. |
ATXI |
Director |
2023-09-08 |
354,318 |
|
0 |
Premium* |
|
|
Journey Medical Ord Shs |
DERM |
Director |
2024-03-25 |
144,245 |
2024-03-25 |
176,470 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
163 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNTAQ |
Genta Inc De |
10% Owner |
– – • |
2003-07-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,000,004) |
1,019,774 |
|
- |
|
| GNTAQ |
Genta Inc De |
10% Owner |
– – • |
2003-07-09 |
4 |
A |
$0.00 |
$0 |
I/I |
6,512,661 |
376,682 |
|
- |
|
| GNTAQ |
Genta Inc De |
10% Owner |
– – • |
2003-07-10 |
4 |
B |
$14.69 |
$73,450 |
D/D |
5,000 |
21,526,885 |
2.45 |
- |
|
| GNTAQ |
Genta Inc De |
10% Owner |
– – • |
2003-07-14 |
4 |
B |
$13.39 |
$66,950 |
D/D |
5,000 |
21,531,885 |
2.45 |
- |
|
| CYPB |
Cypress Bioscience Inc |
10% Owner |
– – • |
2004-01-09 |
4 |
S |
$14.93 |
$3,016,600 |
I/I |
(200,000) |
2,425,848 |
|
- |
|
| CYPB |
Cypress Bioscience Inc |
10% Owner |
– – • |
2004-01-13 |
4 |
S |
$12.07 |
$2,595,050 |
I/I |
(215,000) |
2,210,848 |
|
- |
|
| SNGX |
Soligenix Inc Common |
10% Owner |
– – • |
2004-02-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(886,399) |
3,230,922 |
|
- |
|
| GNTAQ |
Genta Inc De |
10% Owner |
– – • |
2004-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
6,559,725 |
656,191 |
|
- |
|
| GNTAQ |
Genta Inc De |
10% Owner |
– – • |
2004-02-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(9,359,582) |
0 |
|
- |
|
| TGTX |
TG Therapeutics Inc |
10% Owner |
– – • |
2004-08-17 |
4 |
B |
$0.80 |
$8,200 |
D/D |
10,000 |
2,229,521 |
2.37 |
- |
|
| TGTX |
TG Therapeutics Inc |
10% Owner |
– – • |
2004-08-24 |
4 |
B |
$0.80 |
$4,000 |
D/D |
5,000 |
2,234,521 |
2.37 |
- |
|
| TGTX |
TG Therapeutics Inc |
10% Owner |
– – • |
2004-09-03 |
4 |
B |
$0.89 |
$4,450 |
D/D |
5,000 |
2,239,521 |
2.37 |
- |
|
| TGTX |
TG Therapeutics Inc |
10% Owner |
– – • |
2004-09-09 |
4 |
B |
$0.95 |
$950 |
D/D |
1,000 |
2,240,521 |
2.37 |
- |
|
| TGTX |
TG Therapeutics Inc |
10% Owner |
– – • |
2004-09-28 |
4 |
B |
$0.92 |
$9,410 |
D/D |
10,000 |
2,250,521 |
2.37 |
- |
|
| TGTX |
TG Therapeutics Inc |
10% Owner |
– – • |
2004-10-04 |
4 |
B |
$0.89 |
$8,900 |
D/D |
10,000 |
2,260,521 |
2.37 |
- |
|
| TGTX |
TG Therapeutics Inc |
10% Owner |
– – • |
2004-10-13 |
4 |
B |
$0.94 |
$6,110 |
D/D |
6,500 |
2,267,021 |
2.37 |
- |
|
| TGTX |
TG Therapeutics Inc |
10% Owner |
– – • |
2004-10-14 |
4 |
B |
$0.93 |
$3,255 |
D/D |
3,500 |
2,270,521 |
2.37 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • • |
2004-11-09 |
4 |
S |
$11.00 |
$2,709,344 |
I/I |
(246,304) |
194,600 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • • |
2004-11-17 |
4 |
S |
$13.10 |
$929,816 |
I/I |
(71,000) |
123,600 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • • |
2004-11-18 |
4 |
S |
$12.66 |
$246,929 |
I/I |
(19,500) |
104,100 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • • |
2004-11-19 |
4 |
S |
$12.14 |
$252,470 |
I/I |
(20,800) |
83,300 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • • |
2004-11-22 |
4 |
S |
$11.77 |
$529,650 |
I/I |
(45,000) |
38,300 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • • |
2004-11-23 |
4 |
S |
$11.51 |
$440,707 |
I/I |
(38,300) |
0 |
|
- |
|
| TGTX |
TG Therapeutics Inc |
10% Owner |
– – • |
2005-01-06 |
4 |
B |
$1.04 |
$10,400 |
D/D |
10,000 |
2,280,521 |
2.37 |
- |
|
| TGTX |
TG Therapeutics Inc |
10% Owner |
– – • |
2005-01-07 |
4 |
B |
$1.04 |
$10,475 |
D/D |
10,000 |
2,290,521 |
2.37 |
- |
|
163 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
